Patents
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/2000
12/20/2000EP0938309A4 Methods for in vivo reduction of iron levels and compositions useful therefor
12/20/2000EP0830371B1 IMIDAZO(1,5a]PYRIDINE DERIVED SERINE PROTEASE INHIBITORS
12/20/2000EP0714295B1 Fibrinogen receptor antagonists
12/20/2000EP0543858B1 Benzimidazole derivatives, process for their preparation and application
12/20/2000CN1277556A Application of TNF antagonists as medicaments for treating septic diseases
12/20/2000CN1277555A Composition for improving mental capabilities in mammals
12/20/2000CN1277198A New bicyclo aminopyrazineone compound, its producing process and medical composition containing them
12/20/2000CN1277197A Stable crystal salt of 5-methyl tetrahydrofolic acid
12/20/2000CN1277053A Compound tree peony injecta
12/20/2000CN1277034A Chinese medicine preparation
12/20/2000CN1277022A Medical composition for treating thrombus and its use
12/20/2000CN1059590C Medicine for blood generation and preparing method
12/20/2000CN1059566C Method for preparing hemostatic
12/19/2000US6162807 Thio acid derived monocyclic N-heterocyclics as anticoagulants
12/19/2000US6162796 Method for transferring genes to the heart using AAV vectors
12/19/2000US6162790 Oligopeptides
12/19/2000US6162629 Preparing a serine protease solution; eluting protease from column, freeze drying, filtering and recovering protease
12/19/2000US6162427 Treating tumor by administering colony stimulating factor
12/19/2000CA2189527C Novel elastase inhibitors
12/14/2000WO2000075375A1 26 human secreted proteins
12/14/2000WO2000075365A2 Compounds and methods to enhance raav transduction
12/14/2000WO2000075348A1 Recombinant anti-cd40 antibody and uses thereof
12/14/2000WO2000075318A1 Phospholipid transfer protein
12/14/2000WO2000075279A2 Nucleotide sequences for gene regulation and methods of use thereof
12/14/2000WO2000075275A2 Bioreactor design and process for engineering tissue from cells
12/14/2000WO2000075186A1 Neuromedin b and somatostatin receptor agonists
12/14/2000WO2000075172A2 FACTOR VIIa INHIBITORS
12/14/2000WO2000075163A1 Angiogenic proteins and uses thereof
12/14/2000WO2000075134A1 Pyrazinone thrombin inhibitors
12/14/2000WO2000075129A1 Thiophene integrin inhibitors
12/14/2000WO2000075107A2 Bradykinin receptor antagonists
12/14/2000WO2000074725A1 Identification of compounds that modify transcriptional responses to hypoxia
12/14/2000WO2000074724A2 Conjugates comprising cytokines and nucleic acids for treating proliferating cells
12/14/2000WO2000074718A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000WO2000074717A1 NOVEL Ig FRACTIONS HAVING AN IMMUNOMODULATORY ACTIVITY
12/14/2000WO2000074713A1 Autologous thrombin
12/14/2000WO2000074707A2 Use of interleukin-11 to treat hemorrhagic shock
12/14/2000WO2000074701A2 Method and composition for inhibiting cardiovascular cell proliferation
12/14/2000WO2000074695A2 Tanacetum parthenium extract
12/14/2000WO2000074682A1 Thrombin inhibitors
12/14/2000WO2000074681A1 Metalloprotease inhibitors
12/14/2000WO2000074650A2 Implantable gel compositions and method of manufacture
12/14/2000WO2000048624A3 Utilization of orosomucoid in order to produce a pharmaceutical preparation
12/14/2000WO2000046228A3 Pyrrolobenzodiazepine carboxyamide vasopressin agonists
12/14/2000WO2000046225A3 Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
12/14/2000WO2000043498A3 Human liver progenitors
12/14/2000WO2000043032A3 Baff, inhibitors thereof and their use in the modulation of b-cell response
12/14/2000WO2000029378A3 Acyclic and cyclic guanidine- and acetamidine derivatives, their preparation and their use as pesticides, esp. as parasiticides
12/14/2000CA2383828A1 26 human secreted proteins
12/14/2000CA2376506A1 Neuromedin b and somatostatin receptor agonists
12/14/2000CA2376438A1 Identification of compounds that modify transcriptional responses to hypoxia
12/14/2000CA2376400A1 Compounds and methods to enhance raav transduction
12/14/2000CA2376358A1 Use of interleukin-11 to treat hemorrhagic shock
12/14/2000CA2376335A1 Novel ig fractions having an immunomodulatory activity
12/14/2000CA2376039A1 Bioreactor design and process for engineering tissue from cells
12/14/2000CA2376018A1 Angiogenic proteins and uses thereof
12/14/2000CA2375912A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000CA2375882A1 Metalloprotease inhibitors
12/14/2000CA2374654A1 Thrombin inhibitors
12/14/2000CA2374558A1 Phospholipid transfer protein
12/13/2000EP1059302A1 Factor VIIa inhibitors
12/13/2000EP1059092A1 Use of complexes among cationic liposomes and polydeoxyribonucleotides as medicaments
12/13/2000EP1059088A1 New Ig-fractions with immunomodulation activity
12/13/2000EP1059083A2 A solid pharmaceutical preparation for dialysis and a process for producing the same
12/13/2000EP1058692A1 Pf4 fragments and pharmaceutical compositions containing same
12/13/2000EP1058549A1 THROMBIN OR FACTOR Xa INHIBITORS
12/13/2000CN1276726A Method for treating hypercoagulable states or acquired protein C deficiency
12/13/2000CN1059436C Benzoazepine-benzooxaazepine-benzothiaazepin-N-acetate deriv.
12/12/2000US6160176 Anticoagulant agents
12/12/2000US6160108 Platelet activation protein
12/12/2000US6160098 Preparing a fixed erythrocyte transport protein having preferential physical properties; obtain deoxygenated erythrocyte transport protein and controlling physical properties of solution during fixation
12/12/2000US6160097 Regenerating active human polypeptides; freeze liquid containing human polypeptide, lipid and detergent, at a later time melt the liquid
12/12/2000US6159964 Vitronectin receptor antagonists
12/12/2000US6159468 Activated protein C formulations
12/12/2000US6159461 Use of c-kit ligand with TNF-α and hematopoietic factors for the expansion or differentiation of hematopoietic cells
12/11/2000CA2274419A1 Use of complexes among cationic liposomes and polydeoxyribonucleotides as medicaments
12/07/2000WO2000073478A2 Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration
12/07/2000WO2000073456A1 A VARIANT OF C6 β-CHEMOKINE LEUKOTACTIN-1(shLkn-1) WITH ENHANCED BIOLOGICAL ACTIVITY
12/07/2000WO2000073451A1 Mammalian receptor proteins; related reagents and methods
12/07/2000WO2000073450A2 Cytoskeleton-associated proteins
12/07/2000WO2000073449A1 Dna encoding snorf33 receptor
12/07/2000WO2000073443A1 Lipid metabolism transcription factor
12/07/2000WO2000073324A2 Modulation of gene expression in gastrointestinal inflammation
12/07/2000WO2000073323A2 Adam polynucleotides and polypeptides
12/07/2000WO2000073302A1 Oxazaheterocycles as protease inhibitors
12/07/2000WO2000073275A1 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect
12/07/2000WO2000073260A1 Squaric acid derivatives as cell adhesion molecules
12/07/2000WO2000072882A1 Preventives for idiopathic thrombocytopenic purpura
12/07/2000WO2000072845A1 Il-8 receptor antagonists
12/07/2000WO2000072840A1 Il-8 receptor antagonists
12/07/2000WO2000072815A1 Indole derivatives
12/07/2000WO2000046224A3 Tricyclic pyridine n-oxides vasopressin agonists
12/07/2000CA2375855A1 Modulation of gene expression in gastrointestinal inflammation
12/07/2000CA2375683A1 Il-8 receptor antagonists
12/07/2000CA2375218A1 Squaric acid derivatives as cell adhesion molecules
12/07/2000CA2375186A1 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect
12/07/2000CA2375047A1 Dna encoding snorf33 receptor
12/07/2000CA2374409A1 A variant of c6 .beta.-chemokine leukotactin-1(shlkn-1) with enhanced biological activity
12/07/2000CA2374391A1 Mammalian receptor proteins; related reagents and methods
12/07/2000CA2374376A1 Lipid metabolism transcription factor